G. Krähn-Senftleben

Photodynamic therapy with BF‐200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double‐blind, placebo‐controlled phase III study

U. Reinhold, K. Reich, M. Sebastian, 2010, The British journal of dermatology.

Vitamin D supply: from sun or pill? - Attitudes and recommendation on vitamin D and impact on sun protection practices among German general practitioners evaluated by the network of dermato-oncologists, Onkoderm e.V.

U. Reinhold, W. Malaisse, T. Dirschka, 2012, Oncology letters.

Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

V. Godfrey, J. Roberts, M. Karin, 2000, Molecular cell.

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis

C. Berking, H. Hönigsmann, U. Reinhold, 2013, The British journal of dermatology.

Photodynamic therapy with BF‐200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer‐blind phase III study in comparison with a registered methyl‐5‐aminolaevulinate cream and placebo

C. Berking, H. Hönigsmann, U. Reinhold, 2012, The British journal of dermatology.

Methyl aminolevulinate daylight photodynamic therapy applied at home for non‐hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany

S. Karrer, R. Aschoff, G. Gauglitz, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Patient‐reported health outcomes in patients with non‐melanoma skin cancer and actinic keratosis: results from a large‐scale observational study analysing effects of diagnoses and disease progression

M. Koller, R. Szeimies, K. Strömer, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.